![John Leonard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Leonard
Chief Executive Officer at
INTELLIA THERAPEUTICS, INC.
Net worth: 20 M $ as of 30/05/2026
Profile
Presently, John M. Leonard holds the position of President, Chief Executive Officer & Director at Intellia Therapeutics, Inc. Dr. Leonard is also SVP-Global Pharmaceutical Research & Development at Abbott Laboratories and on the board of 6 other companies. Dr. Leonard previously occupied the position of Senior VP-Pharmaceuticals, Research & Development at Abbott Laboratories, CSO, SVP-Pharmaceutical Research & Development at AbbVie, Inc. and Senior Director-Clinical Research at G.H. Besselaar Associates. John M. Leonard received an undergraduate degree from the University of Wisconsin and a doctorate from The Johns Hopkins University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 1,185,775 ( 0.85% ) | 17 M $ | 30/05/2026 | |
IQVIA HOLDINGS INC 0.01% | 22/04/2026 | 16,946 ( 0.01% ) | 3 M $ | 30/05/2026 |
John Leonard active positions
| Companies | Position | Start |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Chief Executive Officer | 31/12/2017 |
| IQVIA HOLDINGS INC. | Director/Board Member | 04/02/2015 |
Tyree & D’Angelo Partners Management LP
 Tyree & D’Angelo Partners Management LP Investment ManagersFinance Tyree & D'Angelo Partners invests in lower middle market companies located in the United States and Canada with revenues less than USD 50 million and EBITDA ranging from USD 1 - 5 million. The firm focuses on companies operating in the healthcare, consumer, and business services sectors. It provides financing for buyout stage capital requirements. The firm acquires controlling stake and also makes co-investments. | Private Equity Investor | - |
IFM Continua, Inc.
 IFM Continua, Inc. BiotechnologyHealth Technology Develops biotechnology products | Director/Board Member | - |
IFM Cinque, Inc.
 IFM Cinque, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Director/Board Member | - |
IFM Quattro, Inc.
 IFM Quattro, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Director/Board Member | - |
IFM Therapeutics LLC
 IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology Discovers and develops small molecules that modulate novel targets in the innate immune system as next generation therapies for cancer, autoimmunity and inflammatory disorders | Director/Board Member | 12/09/2018 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | - |
3T Biosciences, Inc.
 3T Biosciences, Inc. BiotechnologyHealth Technology Operates as an immunotherapy company that develops next-generation and transformative therapies for the treatment of solid tumors and immune-mediated diseases | Director/Board Member | 24/10/2022 |
Former positions of John Leonard
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of John Leonard
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
83
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Quintiles Transnational Holdings, Inc.
 Quintiles Transnational Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical development services and commercial outsourcing services | Commercial Services |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
G.H. Besselaar Associates | |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tyree & D’Angelo Partners Management LP
Tyree & D’Angelo Partners Management LP Investment ManagersFinance Tyree & D'Angelo Partners invests in lower middle market companies located in the United States and Canada with revenues less than USD 50 million and EBITDA ranging from USD 1 - 5 million. The firm focuses on companies operating in the healthcare, consumer, and business services sectors. It provides financing for buyout stage capital requirements. The firm acquires controlling stake and also makes co-investments. | Finance |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
IFM Therapeutics LLC
IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology Discovers and develops small molecules that modulate novel targets in the innate immune system as next generation therapies for cancer, autoimmunity and inflammatory disorders | Health Technology |
IQVIA Holdings, Inc.
 IQVIA Holdings, Inc. BiotechnologyHealth Technology Provides outsourced clinical research and trial, mission critical information, technology, healthcare and patient engagement services | Health Technology |
3T Biosciences, Inc.
3T Biosciences, Inc. BiotechnologyHealth Technology Operates as an immunotherapy company that develops next-generation and transformative therapies for the treatment of solid tumors and immune-mediated diseases | Health Technology |
IFM Cinque, Inc.
IFM Cinque, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
IFM Continua, Inc.
IFM Continua, Inc. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
IFM Quattro, Inc.
IFM Quattro, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Commercial Services |
- Stock Market
- Insiders
- John Leonard
